tetradecanoylphorbol acetate and Hyperlipoproteinemias

tetradecanoylphorbol acetate has been researched along with Hyperlipoproteinemias in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cianflone, K; Genest, J; Sniderman, AD; Zhang, XJ	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Hyperlipoproteinemias

Article	Year
Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB. European journal of clinical investigation, 1998, Volume: 28, Issue:9 Topics: Adult; Aged; Apolipoproteins B; Binding, Competitive; Biological Transport, Active; Blood Proteins; Cell Line; Complement C3a; Female; Fibroblasts; Glucose; Humans; Hyperlipoproteinemias; Insulin; Male; Middle Aged; Tetradecanoylphorbol Acetate; Triglycerides	1998

Article

Year

Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB.

European journal of clinical investigation, 1998, Volume: 28, Issue:9

Topics: Adult; Aged; Apolipoproteins B; Binding, Competitive; Biological Transport, Active; Blood Proteins; Cell Line; Complement C3a; Female; Fibroblasts; Glucose; Humans; Hyperlipoproteinemias; Insulin; Male; Middle Aged; Tetradecanoylphorbol Acetate; Triglycerides

1998